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Abstract: 
Background: Electronic health records (EHR) are being adopted due to numerous 
potential benefits. This requires the development of objective metrics to characterize 
morbidity, comparable to studies performed in centers without an EHR. We outline 
development of an electronic version (E-POMS) of the postoperative morbidity score 
(POMS) for integration into our EHR. 
Methods: 203 frail patients who underwent elective surgery were reviewed. We 
retrospectively defined POMS morbidity on postoperative day 3 (D3). We also recorded 
potential electronic surrogates for morbidities that could not be easily extracted in an 
objective format. We compared discriminative capability (area under the receiver 
operator curve - AUC) for patients having prolonged length of stay (pLOS) or complex 
discharge requirements (CD). 
Results: 139 patients (68%) had morbidity in at least one POMS domain. Initial 
electronic surrogates were overly sensitive, identifying 173 patients (84%) as having 
morbidity. We refined our definitions using backwards logistic regression against ‘gold-
standard’ POMS. The final E-POMS differed from the initial version in its definition of 
cardiac and neurological morbidity. There was no significant difference in discriminative 
capability between  E-POMS and POMS for either outcome (AUC 0.66 v 0.66 for CD, 
AUC 0.66 v 0.67 for pLOS, 𝑝 > 0.05 for both). Patients with POMS or E-POMS defined 
morbidity on D3 had increased risk of prolonged length of stay (𝑝 < 0.001 for both) 
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Conclusions: We present a variant of POMS based on objective electronic metrics. 
Discriminative performance appeared comparable to gold-standard definitions for 
discharge outcomes. E-POMS may allow characterization of morbidity within our EHR 
but further work is required to assess external validity. 
 
 
Key Points: 
Question: Can surrogates for a validated post-operative morbidity score be extracted from 
an electronic patient record? 
Findings: Use of electronic surrogates for previously published definitions had 
comparable discriminative power for the identification of patients at risk of clinically 
relevant discharge outcomes. 
Meaning: As increasing numbers of hospitals adopt electronic health records, local 
development of such measures is vital to assess performance and characterize patient 
outcome.  
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Introduction 
Defining postoperative morbidity is vital for measuring patient outcomes as well as 
quantifying the risks of specific interventions. Risk scores are often used to quantify such 
information for patients and clinicians1. Importantly, how complications are defined may 
lead to differences in reported incidences;2 as such, the use of standardized outcome 
measures is to be advocated. Ongoing work is looking to develop a consensus set of 
outcomes for perioperative medicine 3.  
The ‘Perioperative Quality Improvement Program’ (PQIP) in the United Kingdom 
includes identification of operative morbidity as a core indicator of patient outcome4. 
PQIP defines postoperative morbidity using the “Postoperative Morbidity Score” 
(POMS). This records morbidity across nine organ system domains (Table 1). Initially 
studied in a surgically heterogeneous population of 438 individuals in the United States5, 
the score was calculated prospectively on days 3, 5, 8, and 15. Calculation was based on 
medical notes, patient assessment, and discussion with caregivers. A modification of the 
score was assessed in the United Kingdom in 2007 in a mixed surgical cohort6.  
Subsequent work demonstrated that retrospective collection of POMS data was non-
inferior 7. 
In perioperative medicine, large datasets are required to draw inferences due to 
heterogeneity of practice. This is only feasible if data extraction can be automated. Many 
hospitals are acquiring integrated electronic health record systems (EHR). Such systems 
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offer improved legibility, accuracy, and opportunities for perioperative research8. The 
epidemiological advantages extend beyond the direct realms of anesthetic practice; 
information has been used to characterize trends in management of coronary artery 
disease in patients presenting for surgery9. These benefits rely on information being 
coded in a readily extractable, objective format. It is vital to identify markers within the 
EHR which can replace laborious hand-searching of free text components. Unfortunately, 
the POMS score contains elements which require note review for interpretation. An 
electronic version is therefore needed to facilitate ‘big data’ analysis. Any derived score 
needs validation against the original version to ensure interoperability. 
We aimed to generate an ‘electronic variant of the POMS’ (“E-POMS”) that could be 
integrated into our EHR for our ongoing quality improvement work. Using a dataset of 
frail patients undergoing elective surgery we undertook a process of notes review to 
evaluate morbidity as defined by POMS. Alongside we extracted electronic markers of 
morbidity that we would explore as surrogates. We compared E-POMS to the original 
POMS for identifying discharge outcomes of interest.   
Methods 
Approval 
Work was conducted as part of a retrospective service evaluation and quality 
improvement project. Approval was granted by our hospital trust’s Patient Safety 
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Department (local reference PRN6715). Being as this was a retrospective analysis the 
patient safety department made no request for the gaining of informed consent.  
Setting: 
Addenbrooke’s Hospital is a tertiary surgical center located in Cambridge, United 
Kingdom. A hospital wide EHR with an integrated Anesthesia Information Management 
System (AIMS) (Epic Systems Inc, Verona-WI) has been in use since 2014. This 
provides readily available information on intraoperative events as well as pre-operative 
and postoperative information. Laboratory results, observations, comorbidities, and 
prescriptions are all exportable, and linked to specific hospital encounters. Prior to 
elective surgery, patients are routinely reviewed in a multi-disciplinary pre-assessment 
clinic if they are identified as ‘frail’ (Rockwood clinical frailty scale - CFS of 4 or 
more)10. Here they are reviewed by a consultant anesthetist and consultant geriatrician 
alongside a physiotherapist and occupational therapist.  
Patient population 
We included all patients who had attended our multi-disciplinary pre-assessment clinic 
from January 2016 to the end of June 2017. Those that did not proceed to surgery, had 
yet to undergo their operation or were less than 30 days from surgery were excluded. We 
identified morbidity on postoperative day 3 (D3). This decision was based on previous 
work demonstrating highest incidence of morbidity at this time-point,11 therefore we only 
included patients with a length of stay of 3 days or longer. 
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Definitions: 
We retrospectively searched our EHR on D3 for evidence of complications as defined by 
the POMS. Certain modifications (noted in Table 1 and referenced) were made. This 
involved the searching of electronic observation charts, medical notes, and drug charts. 
POMS domains were scored as present or absent. We prospectively defined potential 
electronic surrogates for POMS domains (Table 1). In many cases these were identical to 
the literature standard. Surrogates were chosen with the intention of mapping to the 
original definition (e.g. furosemide prescription as a surrogate for pulmonary edema).  
The presence of these electronic definitions were also extracted. With the following 
caveats, all data were extracted on calendar D3; postoperative creatinine samples were 
included from D2 to D4, further operations for wound exploration were included in a 12-
hour period on either side of postoperative day 3. Literature standard cardiovascular 
complications were included in the 24-hour period running from D3 retrospectively into 
D2.  Data for the electronic definitions was recorded ‘blind’ without interpretation in 
light of other information (i.e. if no urine output was recorded as the patient was not 
catheterized, then this was recorded as a urine output of < 500 ml/24hrs). When no 
suitable postoperative creatinine was available the pre- to postoperative creatinine ratio 
was recorded as 0 and included in analysis.  A positive troponin test was defined as a 
result above the normal range for our institution (Troponin I 0-5ng/L). 
Outcomes 
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We assessed performance of both POMS and E-POMS against predefined outcomes. 
Firstly ‘complex discharge’ (CD: a composite of whether an individual required 
discharge to another institution or their own home with an altered care package) or 
‘prolonged length of stay’ (pLOS; a hospital stay of 8 days or more). 
Statistical analysis 
All analysis was performed in R (R Core Team (2018). R: A language and environment 
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 
http://www.r-project.org/) Comparison of initial distributions of POMS and E-POMS was 
conducted using the Wilcoxon signed rank test. Scoring systems were compared as; a 
binary outcome (any complication yes/no), an additive score (0-9, depending on the 
number of domains an individual was positive for) and with regression of all domain 
predictors against each outcome. For refinement of electronic definitions, candidate 
surrogates were regressed against a ‘gold standard’ outcome as defined by the POMS 
criteria. Backwards logistic regression was performed using the ‘step’ function in R. 
Simplified models were compared using analysis of deviance (likelihood ratio) testing to 
ensure that simplification had caused a non-significant change in explained variance.  
Impact of this process was assessed by the generation of classifier metrics including 
sensitivity, specificity, and positive and negative predictive values for the ability of 
initial, and refined EPOMS scores to identify differing levels of POMS morbidity. Model 
discrimination was assessed using area under the receiver operator curve (AUC). The 
final score was compared to POMS for the discrimination of our outcomes of interest. 
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Calibration was assessed using cross-calibration plots. Here morbidity predictions 
generated by logistic regression models based on literature POMS and E-POMS 
definitions were correlated against each other. The equation of the resulting correlation 
line allows for an interpretation of systemic offset between the two models (the intercept, 
‘calibration in the large’) as well as the calibration slope. An ideal model would have 
values of 0 and 1 for each of these respectively 11.  Finally, Kaplan-Meier curves were 
constructed for length of stay in days against those patients found to be POMS or 
EPOMS positive/negative. Significance of survival analysis was performed using the log-
rank test.  In all circumstances, unless otherwise stated, a P value of 0.05 was taken as the 
threshold for significance. 
Results 
207 patients from our initial cohort of 332 had a length of stay of 3 days or more. Of 
these, 4 died as an inpatient and were excluded from further analysis leaving a final 
dataset of 203 patients. Median length of stay (LOS) was 7 days (interquartile range 5-
11). 48 (24%) had a complex discharge. 94 patients (46%) had pLOS. The majority (112 
- 55%) underwent orthopedic surgery. 24 (12%) underwent general surgical procedures, 
20 (10%) urological procedures and 19 (9%), vascular surgery.  Mean (standard 
deviation) age was 80 (7.8). 107 (53%) were female.   
Incidence of morbidity 
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On D3 139 (68%) patients had morbidity in at least one POMS domain. Initial electronic 
definitions identified 173 (84%) patients with morbidity in at least one domain. 
Distribution of incidence of both scores is demonstrated in Figure 1. The difference in 
occurrence of morbidity was statistically significant (p < 0.001). Supplementary Table 1 
identifies mismatch between our initial electronic score and POMS.   
Domains where our new score is based entirely on the POMS score demonstrate exact 
matching. However our surrogates for cardiac, renal, and neurological domains appeared 
to be overly sensitive, identifying more patients than POMS. Using anti-emetic 
prescriptions alone we missed three patients with gastrointestinal morbidity. Being as this 
modification had previously been made to the POMS score6 we did not consider this 
domain for refinement. 
Performance of initial EPOMS 
We assessed the performance of our initial score for identifying patients with any level of 
POMS defined morbidity (i.e. any domain positive).  Test performance metrics are shown 
in Table 2.  Our initial score demonstrated high sensitivity (99.3%) but was relatively 
non-specific (45.3%).   
Discriminative performance of initial score 
Presence of any POMS morbidity on D3 had an AUC of 0.61 [95% Confidence Interval 
0.54-0.67] for discriminating between patients with pLOS. For initial electronic 
definitions AUC was 0.53 [0.48-0.58](𝑝 < 0.01). For CD the AUCs were 0.57 [0.50-
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0.64] and 0.53 [0.48- 0.58] for POMS, and electronic definitions, respectively, indicating 
non-significant discriminative capability(𝑝 = 0.29. We explored discrimination of 
definitions when employed as an ordinal score (0-9) or as a regression model of all 
domains.  Highest AUCs were found with a regression model of all domains: 0.67[0.57-
0.76] (POMS) v 0.68[0.59-0.76] (electronic) for CD and 0.67[0.60-0.75] (POMS) v 
0.69[0.62-0.76] (electronic) for pLOS. 
Refining domain definitions 
We sought to refine the initial definitions of cardiac, neurological, and renal morbidity in 
an effort to improve overall E-POMS performance.  This was done using backwards 
regression of our initial surrogates in a specific domain against positivity in the POMS 
domain of interest. The end results of this process are the domain definitions presented in 
Table 3 which form our final E-POMS score. New domain definitions had AUCs of 
0.68[0.56-0.81] (cardiac), 0.86 [0.75-0.97] (neurological), and 0.97 [0.92-1.00] (renal) for 
the discrimination of individuals classed as positive in the corresponding POMS domain.  
In all cases, analysis of deviance testing of simplified models indicated a non-significant 
change in explained variance (P > 0.05 for all).  Classifier performance of the final score 
is shown in Table 2.  Changes in positivity across domains compared to POMS and our 
initial score is shown in Supplementary Table S1.   
Final E-POMS 
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Correlation of final E-POMS and POMS totals was performed, this indicated good 
correlation (Spearman’s 𝜌 = 0.88; 𝑝 < 0.0001). We formed logistic regression models 
using all domains of final E-POMS. This was compared against a logistic regression 
model consisting of all domains of POMS. Receiver operator curves (ROC) for both 
outcomes are demonstrated in Figure 2. There was no significant difference in 
discriminative capability between final E-POMS and POMS for either outcome (AUC 
0.66 [0.57-0.75] v 0.66[0.57- 0.76] for complex discharge, AUC 0.66 [0.59-0.74] v 0.67 
[0.60-0.75] for pLOS, 𝑝 > 0.05for both). Cross-calibration plots of generated predictions 
from both models for both outcomes were generated. These demonstrated little offset 
(intercepts 0.042 and 0.036 for pLOS and CD respectively). Calibration slopes for both 
were < 1 (0.91 and 0.85) indicating a degree of optimism in predictions.  As a binary 
classifier the final variant of EPOMS demonstrated improved specificity (78.1%) and 
positive predictive value (90.1%) for identification of POMS defined morbidity when 
compared to our initial score (Table 2).  This trend was seen for the identification of all 
levels of morbidity (with a corresponding increase in overall accuracy) but, at higher 
levels was associated with a decreasing level of sensitivity.  When assessed as an additive 
score (i.e. total domains positive on a scale of 0-9), agreement between the total POMS 
and total EPOMS score improved from 45.8% using initial definitions to 69.5% using our 
final version.   
We assessed the impact of accumulating morbidity on discrimination of CD and pLOS by 
identifying patients with  total POMS and EPOMS scores of 2 or more, or 3 or more.  All 
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resulting AUCs were <0.57 with no significant difference between POMS and EPOMS 
(P> 0.05).   
Kaplan-Meier curves for length of stay dichotomized by D3 morbidity defined by either 
POMS or E-POMS scores of ≥ 1 versus no morbidity are shown in Figure 3. Both 
identified patients with an increased hazard of longer length of stay (from D3 onwards) 
(P <0.01 log-rank hazard score) Even after removal of an outlying patient with a LOS > 
100 days these findings remained significant (data not shown). 
Discussion 
The POMS is a multi-dimensional outcome score that has been employed in different 
healthcare settings5-6 and is currently being used as an outcome metric in a national 
quality improvement program (PQIP) being run by the Royal College of Anaesthetists in 
the United Kingdom4.  We present a version of the POMS whose constituents can be 
readily extracted from our EHR and whose performance appeared comparable to the 
original for discrimination of clinically relevant discharge outcomes.  Our final list of 
variables is only significantly different from the original POMS within the cardiac and 
neurological domains. External validity cannot be inferred from a single center study but 
the approach we have taken may be of interest to those looking to develop local EHR 
metrics of morbidity. 
There are certain caveats that need to be discussed. Firstly, the score has been developed 
on a modestly sized dataset derived from a single center using retrospective data. Since 
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calculation of the original POMS requires note review, this limits the size of sample that 
can be realistically assessed. We utilized a single time point to make the amount of 
manual note-searching tractable. Given its similarity to the original definitions of POMS, 
it is likely the score will have similar discriminative capability when applied at different 
time points, however this awaits confirmation.  Importantly, this introduces an element of 
bias into our results as it is possible we have selected complications occurring due to 
distinct causes than at earlier or later timepoints.  For instance presence of oxygen 
therapy on post-operative day zero or one may simply reflect residual anaesthetic effect.  
Use of the score at distinct temporal points and with reference to accumulated duration of 
morbidity is necessary to explore the impact and importance of any bias resulting from 
our methods.  Secondly, although at a population level the discriminative capability of 
the two scores is not significantly different, this will not necessarily hold true at the level 
of an individual. This will mean there will be individuals classed as morbidity ’positive’ 
or ’negative’ differently by these, and other surrogate markers.  To some extent this could 
be mitigated by co-linearity inherent within POMS; for instance a patient suffering from 
pulmonary edema is likely to be receiving oxygen and thus will score for both the cardiac 
and respiratory domains. These differences may be less relevant in analyses that involve 
patient populations, but the clinical expectations of outcome that derive from a given 
POMS score in an individual may not translate faithfully when an EPOMS score is used 
at its current level of development.  Consequently, we would urge caution in this context 
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until further experience and refinement of EPOMS methodology allow more reliable 
clinical inferences.  
Assessment of the classifier performance of EPOMS for the identification of POMS 
defined morbidity demonstrates important information on our methodology, the utility of 
the score as a screening tool,  and the need for validation in larger data sets.  Broadly the 
process of domain refinement improved the specificity, and thus overall accuracy, of our 
final version of EPOMS (Table 2).  This  demonstrates that our methodological process 
of definition refinement was valid and is likely due to a reduction in the number of ‘false 
positives’ driven by the overly sensitive cardiovascular domain.  The final scores’ 
increased specificity and positive predictive value compared to the initial variant 
highlight its improved (but not perfect) ability to identify the individual with morbidity, 
as defined by POMS.  When used to identify patients with multiple morbidities there is a 
tail off in sensitivity in the revised version – this could be due to the refinement of the 
cardiovascular domain, and lower numbers of patients suffering ‘rarer’ complications for 
which our definitions require further refinement.  This can only be tested in a larger 
dataset.  As a binary classifier the final version of EPOMS demonstrates excellent 
sensitivity (>99%) and reasonable specificity (78%).  The high sensitivity means that it 
would be well suited for the screening of patients at risk of deterioration, as very few 
(less than one in a hundred) patients with POMS defined morbidity would be missed.   
Finally, our results indicate that certain domains (particularly cardiac) require refinement.  
Performance in the final model may be improved due to co-linearity but it is possible that 
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the introduction of other surrogates further removed from the original POMS (e.g. new 
prescriptions of cardiac medications) may offer even better performance.  Whereas our 
cardiac definitions are likely to be overly sensitive (arguably of benefit if a score were to 
be used to identify deteriorating patients to prevent ‘failure to rescue’) the criteria for 
wound infection are likely insensitive.  Our chosen definition (need for an operation to 
explore the wound) is in keeping with the original POMS definition but will only identify 
a minority of very severe cases.  However, we hypothesise that in a larger dataset patients 
with lesser degrees of surgical site infection would be identified by the fever and 
antibiotic use encapsulated within the ‘Infectious’ domain definitions.    
We explicitly aimed to identify surrogate markers that could be extracted in an 
unambiguous format, and which are likely to be EHR platform agnostic.  We also sought 
markers that did not require other information for their interpretation. For instance, the 
use of furosemide prescriptions as a surrogate for pulmonary edema identified a number 
of patients receiving it chronically, thus its blanket inclusion would have worsened our 
specificity.  Definitions were chosen so our score could, in theory, be integrated within an 
EHR. Having EPOMS embedded within an EHR raises the possibility of using it to track 
patient outcome in ‘real-time’ to identify patients requiring medical input. This could be a 
method for preventing ’failure to rescue’.12 However, due to difficulty with 
discriminating down to the level of individual organ systems, the exact format and 
thresholds to prompt such review can only be established from prospective work.   
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Others have already looked at identifying patients with a known disease state using 
information extractable from a primary care electronic record. They used markers 
(including prescriptions, blood results, body mass index) to develop algorithms that could 
identify cases of diabetes that had not been accurately coded within the EHR 13. This 
work is analogous to our approach where a disease state (occurrence of a specific organ 
dysfunction) has been recorded in free text but not in a manner that can be readily 
identified on searching of the EHR. 
The markers that we have extracted to generate E-POMS are based on practice in our 
institution. Other hospitals may have different or better surrogates that could be used. 
One marker worth considering is our use of a recorded ‘specialling scoring tool’ (SST) as 
a surrogate for the confused patient. Our hospital uses the SST to aid in the identification 
of patients requiring higher intensity nursing for  behavioural, cognitive, environmental, 
or psychological reasons. We used the presence of a completed score (of any value) as a 
marker of needing closer nursing for delirium.  It is possible that use of specific 
components of the score, rather than its completion per se, may offer greater specificity.  
Within the United Kingdom, the National Institute for Health and Care Excellence 
(NICE) mandate that all hospitals have a mechanism for recording the need for higher 
intensity nursing14.  Other institutions may record this in a different format but  we 
hypothesize it will likely be recorded in a comprehensive EHR.  Other hospitals may 
already record validated delirium screening tools, we have, (subsequent to this analysis),  
implemented a delirium screening tool (‘The 4AT’)15 for patients aged over 65. This 
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would theoretically offer a greater degree of both specificity and sensitivity by 
identifying those with hypoactive delirium in a way that our use of the SST may not. Its 
inclusion would be an easy modification to our tool and, in fact, would simply reflect an 
electronic record of the original POMS criteria rather than being a true surrogate. 
It is important to note that retrospective application of the POMS itself may miss patients 
with significant morbidity. For instance, identification of patients with neurological 
complications does not require a formal delirium screening tool, merely documentation of 
‘confusion, coma or delirium’. Thus patients with hypoactive or less severe hyperactive 
delirium may be missed retrospectively.  As such, certain definitions within the POMS 
are likely to be specific but not sensitive.  
Mathematically, it would have been possible to simplify both EPOMS and POMS during 
the regression process. We have intentionally avoided this for two reasons. Firstly, we 
aimed to develop a score that was recognizable to clinicians who may have already 
encountered the POMS. Consequently, we elected to keep domain number and 
classifications the same. Secondly, we recognized that the incidence of specific 
complications (e.g. focal neurology) within our sample was low. Therefore, although the 
exclusion of “CT Head” had minimal mathematical impact, this might not be the case in a 
larger sample. This lack of simplification raises the risk of model overfitting due to our 
event per variable ratio (EPV)16. Overfitting describes a model which loses its 
generalizability by being too closely tailored to the data it has been developed from. An 
EPV of ten is often advocated to minimize this risk16. For the prediction of pLOS our 
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EPV is ten (nine predictors against 94 outcomes) but for CD is closer to five (9 predictors 
against 48 outcomes). That our calibration slopes for both outcomes had gradients of  <1 
can also be interpreted as a sign of overfitting11. 
 
Conclusion 
We present a variant of POMS whose constituents are readily extractable from an EHR. 
Surrogate markers were based on original definitions and the resulting score had 
comparable discriminative power to POMS for the prediction of discharge related 
outcomes when calculated on D3.   
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Domain POMS Electronic Surrogates 
Pulmonary Requirement for supplemental 
oxygen or other respiratory 
support 
As per POMS 
Infectious On antibiotics or temperature of 
38oC or higher in last 24 hrs 
As per POMS 
Renal Presence of oliguria 
(<500ml/24hrs), rise in serum 
creatinine of > 30% from 
baseline 
As per POMS 
Haematological Requirement for blood, platelets, 
FFP, or cryoprecipitate in last 24 
hrs 
As per POMS 
Pain Wound pain requiring parenteral 
opiates or regional anesthesia 
Active patient controlled 
analgesic or regional 
anaesthetic infusion 
(epidural/wound catheter) 
prescription 
Gastrointestinal* Unable to tolerate an enteral diet 
due to nausea, vomiting and 
Anti-emetic administration 
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abdominal distension OR use of 
an anti-emetic6 
Cardiovascular* Test or therapy in last 24 hrs for 
myocardial infarction or 
ischaemia, hypotension 
requiring drug therapy or fluid > 
200ml/hr, atrial or ventricular 
arrhythmia or pulmonary 
oedema 
HR > 100 bpm, SBP < 100 
mmHg, furosemide 
prescription, positive 
troponin test 
Neurological* New focal deficit, 
coma/confusion/delirium 
Request for CT Head scan 
OR recorded specialling 
screening tool 
Wound* Wound dehiscence requiring 
surgical exploration or drainage 
of pus from the wound 
Further operation 
performed 
 
Table 1: Definitions of morbidity according to the Postoperative Morbidity Score 
(POMS) and our initial electronic surrogates.  Asterisks represent domains where these 
definitions differ. BPM = beats per minutes. FFP = Fresh Frozen Plasma 
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 Versus POMS of 1 or more 
 Initial EPOMS Final EPOMS 
Sensitivity (%) 99.3 99.3 
Specificity (%) 45.3 78.1 
NPV 96.7 98.0 
PPV 79.8 90.1 
Accuracy (%) 82.3 92.6 
 Versus POMS of 2 or more 
 Initial EPOMS Final EPOMS 
Sensitivity (%) 95.9 90.4 
Specificity (%) 63.9 85.4 
NPV 96.5 94.1 
PPV 59.8 77.7 
Accuracy (%) 75.4 87.2 
 Versus POMS of 3 or more 
 Initial EPOMS Final EPOMS 
Sensitivity (%) 91.7 83.3 
Specificity (%) 84.4 94.0 
NPV 97.9 96.3 
PPV 55.9 75.0 
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Accuracy (%) 85.7 92.1 
 
Table 2: Test performance metrics for EPOMS at identifying presence of any POMS 
morbidity before (Initial EPOMS) and after (Final EPOMS) refinement of domain 
definitions.  Classifier performance given for the identification of: any complication, 2 or 
more complications, 3 or more complications. Full confusion matrices used in 
calculations can be found in Supplementary Table S2 (A-F).  NPV = Negative Predictive 
Value, PPV = Positive Predictive Value.    
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Domain Final E-POMS definition 
Pulmonary Supplemental oxygen recorded OR 
respiratory support recorded 
 
Infectious On antibiotics or temperature of 38oC or 
higher in last 24 hrs 
 
Renal* Rise in serum creatinine of > 30% from 
baseline 
 
Haematological Requirement for blood, platelets, FFP or 
cryoprecipitate in last 24 hrs 
 
Pain Active patient controlled analgesic or 
regional anaesthetic infusion prescription 
 
Gastrointesinal Anti-emetic administration 
 
Cardiovascular* HR > 100bpm OR positive troponin 
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Neurological* Recorded specialling scoring tool OR CT 
Head 
 
Wound Further operation 
 
 
Table 3 Final definitions for our derived electronic POMS (E-POMS), FFP: Fresh Frozen 
Plasma. *Indicates domain definition modified from original POMS definitions.   
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Figure Legends 
Figure 1: Histograms demonstrating distribution of morbidity in our patient population 
using initial definitions of an electronic score (A) or using previously published 
definitions for POMS (B).  
 
Figure 2: Receiver Operator Curves (ROC) demonstrating discriminative capability of 
POMS and EPOMS for the identification of complex discharge (A) and prolonged LOS 
(B). For AUC values see text 
 
Figure 3: Kaplan-Meier curves demonstrating length of stay for patients dichotomised by 
the presence of absence of comorbidity on D3 using: A, EPOMS definitions and B, 
POMS definitions.  Tables demonstrate number of patients each category at each time 
point.  
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Supplementary Material Legends 
Supplemental Table 1:  Difference in incidence of morbidity using POMS 
(Postoperative Morbidity Score) or our initial electronic markers 
Supplementary Tables 2 A-F: Confusion matrices assessing performance of initial 
electronic definitions (tables A, C, E) or final EPOMS definitions (tables B, D, F) for the 
identification of differing degrees of POMS defined morbidity (total POMS score: ≥1, 
≥2, ≥3).  A-B: Performance of both definitions when 1 or more domains is positive.  C-
D: when 2 or more domains positive. E-F: when 3 or more domains positive. TP = True 
Positive, FP = False Positive, FN= False Negative, TN = True Negative 
 
Calculations used: 
Sensitivity = TP/(TP+FN), Specificity = (TN/TN+FP), Negative Predictive Value = 
(TN/TN+FN), Positive Predcitive Value = (TP/TP+FP) 
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Figure 1 Click here to access/download;Figure;fig1_new.tiff
Figure 2 Click here to access/download;Figure;figure2_new.tif
Figure 3 Click here to access/download;Figure;figure3_new.tif
 Domain POMS (n) Initial EPOMS 
Score (n) 
Final EPOMS Score (n) 
Pulmonary 75 75 75 
Cardiac 20 101 43 
Infectious 79 79 79 
Wound 1 1 1 
Haematological 11 11 11 
Pain 34 34 34 
GI 23 20 20 
Neurological 18 20 13 
Renal 31 48 29 
 
Supplementary Table 1: Difference in incidence of morbidity using POMS (Postoperative 
Morbidity Score) or our initial electronic markers 
 
 POMS + POMS - 
Initial EPOMS + 138 (TP) 35 (FP) 
Initial EPOMS -  1 (FN) 29 (TN) 
(A) 
 
Supplemental Data File (.doc, .tif, .pdf, etc., Published Online
Only)
 POMS + POMS - 
Final EPOMS + 138 (TP) 14 (FP) 
Final EPOMS -  1 (FN) 50 (TN) 
(B) 
 
 
 
 
 
 2 or more POMS + POMS - 
2 or more Initial EPOMS + 70(TP) 47(FP) 
< 2 Initial EPOMS  3(FN) 83(TN) 
(C) 
 
 2 or more POMS + <2 POMS  
2 or more Final EPOMS + 66 (TP) 19 (FP) 
< 2 Final EPOMS  7 (FN) 111 (TN) 
(D) 
 
 
 3 or more POMS + <3 POMS  
3 or more Initial EPOMS + 33 (TP) 26 (FP) 
<3 Initial EPOMS  3 (FN) 141 (TN) 
(E) 
 
 3 or more POMS + < 3 POMS  
3 or more Final EPOMS + 30 (TP) 10 (FP) 
< 3 Final EPOMS  6 (FN) 157 (TN) 
(F) 
 
Supplementary Tables 2 A-F: Confusion matrices assessing performance of initial electronic 
definitions (tables A, C, E) or final EPOMS definitions (tables B, D, F) for the identification of 
differing degrees of POMS defined morbidity (total POMS score: ≥1, ≥2, ≥3).  A-B: Performance 
of both definitions when 1 or more domains is positive.  C-D: when 2 or more domains positive. E-
F: when 3 or more domains positive. TP = True Positive, FP = False Positive, FN= False Negative, 
TN = True Negative 
 
Calculations used: 
Sensitivity = TP/(TP+FN), Specificity = (TN/TN+FP), Negative Predictive Value = (TN/TN+FN), 
Positive Predcitive Value = (TP/TP+FP) 
